The significance of metabolic disease in degenerative cervical myelopathy: a systematic review

Celine Iswarya Partha Sarathi(University of Cambridge), Oliver Mowforth(University of Cambridge), Benjamin M. Davies(University of Cambridge), Aniqah Bhatti(University of Cambridge), Amir Rafati Fard(University of Cambridge), Aria Nouri(University Hospital of Geneva), Faheem Bhatti(University of Cambridge), Melika Akhbari(University of Cambridge), Amil Sinha(University of Cambridge), Tanzil Rujeedawa(University of Cambridge), Shahzaib Ahmed(East Carolina University), Mark Kotter(Wellcome/MRC Cambridge Stem Cell Institute)
Frontiers in Neurology
February 5, 2024
10.3389/fneur.2024.1301003
Cited by 5

Related Papers

Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
|The Lancet|2025|153
ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?
|BMJ Health & Care Informatics|2023|92
The value of Clinical signs in the diagnosis of Degenerative Cervical Myelopathy - A Systematic review and Meta-analysis
|Global Spine Journal|2023|38
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease
|Journal of Clinical Medicine|2021|36
The Frequency of Symptoms in Patients With a Diagnosis of Degenerative Cervical Myelopathy: Results of a Scoping Review
|Global Spine Journal|2023|28